Corient Private Wealth LLC Sells 5,503 Shares of Exelon Co. (NASDAQ:EXC)

Corient Private Wealth LLC reduced its holdings in shares of Exelon Co. (NASDAQ:EXC) by 2.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 210,014 shares of the company’s stock after selling 5,503 shares during the period. Corient Private Wealth LLC’s holdings in Exelon were worth $7,905,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. JPMorgan Chase & Co. boosted its holdings in shares of Exelon by 109.0% in the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock valued at $238,608,000 after purchasing an additional 3,068,309 shares during the period. Amundi grew its position in shares of Exelon by 53.8% during the 4th quarter. Amundi now owns 6,174,458 shares of the company’s stock worth $235,390,000 after buying an additional 2,160,201 shares in the last quarter. State Street Corp increased its stake in shares of Exelon by 3.7% during the third quarter. State Street Corp now owns 60,169,219 shares of the company’s stock valued at $2,439,862,000 after buying an additional 2,156,259 shares during the period. Nordea Investment Management AB lifted its stake in Exelon by 418.1% in the fourth quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company’s stock worth $94,152,000 after acquiring an additional 2,018,604 shares during the period. Finally, FMR LLC increased its position in Exelon by 18.7% during the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after purchasing an additional 1,858,502 shares during the period. Hedge funds and other institutional investors own 80.92% of the company’s stock.

Exelon Price Performance

Shares of EXC stock opened at $44.59 on Friday. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $45.20. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.78 and a current ratio of 0.87. The firm has a market capitalization of $44.82 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 2.86 and a beta of 0.51. The stock’s 50-day simple moving average is $41.84 and its 200-day simple moving average is $39.91.

Exelon (NASDAQ:EXC) last released its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter in the prior year, the firm posted $0.60 EPS. As a group, equities analysts forecast that Exelon Co. will post 2.64 earnings per share for the current fiscal year.

Exelon Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $1.60 dividend on an annualized basis and a yield of 3.59%. This is a boost from Exelon’s previous quarterly dividend of $0.38. Exelon’s payout ratio is currently 65.31%.

Insider Buying and Selling at Exelon

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the completion of the sale, the executive vice president now directly owns 2,271 shares in the company, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.10% of the company’s stock.

Analyst Upgrades and Downgrades

EXC has been the topic of a number of recent research reports. Evercore ISI upgraded shares of Exelon from an “in-line” rating to an “outperform” rating and increased their price objective for the company from $43.00 to $44.00 in a research note on Tuesday, January 21st. BMO Capital Markets reissued an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Barclays raised their price objective on Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a research report on Tuesday, February 25th. Scotiabank boosted their target price on shares of Exelon from $42.00 to $44.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Finally, Morgan Stanley raised their price target on shares of Exelon from $46.00 to $48.00 and gave the company an “equal weight” rating in a report on Thursday. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, Exelon has a consensus rating of “Moderate Buy” and an average target price of $44.63.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.